NASDAQ:RNXT
RenovoRx, Inc. Stock Company Profile
$1.40
+0.0300 (+2.19%)
At Close: May 20, 2024
Information
4546 El Camino Real, Suite B1
Los Altos CA 94022
650 284 4433
renovorx.com
Industry: Biotechnology
Sector: Healthcare
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
